Its now March 1. 6 weeks from CC.
Given the info provided on the call, I'd expect the feeding and waiting part of the current testing process is close to or has already ended (this assertion is based on previous info derived from WSU testing). Once that part is done it is all about testing the samples .... one by one. On the CC we were led to believe that this test encompassed more fractional components than previous tests. Its anyone's guess how long it will take Battelle to go through the testing and evaluation process .....
Its unclear to me whether the 1st set of tests or the second set of tests is expected to yield the class of compound. Its clear the 1st test is partly an elimination round for more purified fractions or individual molecules. But presumably if there are more purified fractions that continue to show bioactivity against the target, I'd think HEPI has got to be pretty close to establishing the class of compound which allows Dahl to "lay the groundwork for strategic relationships and product development in advance of final identification and characterization."
Looks like a buyer stepped up a clean out all the shares that were sitting the past couple days between .17 and .18. Have to see if more show up today.
Looking forward to news from HEPI.